Rothwell Investment Advisors, LLC’s Fulgent Genetics FLGT Stock Holding History

Rothwell Investment Advisors, LLC’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$66	Buy	+3	New	+$60	﹤0.01%	1112

Other funds holding FLGT

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Peapod Lane Capital Bedford Hills, New York $134M AUM 63.91% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return

Rothwell Investment Advisors, LLC's FLGT Position: Q3 2026 in Review

Rothwell Investment Advisors, LLC opened a new position in Fulgent Genetics (FLGT) in Q3 2026: 3 shares worth $66. The stake represents ﹤0.01% of the portfolio and ranks #1112 among its holdings.

47 funds tracked by Wall St. Rank hold FLGT as of Q3 2026.

Rothwell Investment Advisors, LLC held 3 shares of Fulgent Genetics worth $66 as of Q3 2026.
Fulgent Genetics was a new Rothwell Investment Advisors, LLC position in Q3 2026.
Fulgent Genetics made up ﹤0.01% of Rothwell Investment Advisors, LLC's portfolio in Q3 2026, its #1112 holding.
47 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2026.

Based on Rothwell Investment Advisors, LLC's 13F filing for Q3 2026, filed 6 Nov 2026.